US 7993866
Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen
granted A61PA61P1/04
Quick answer
US patent 7993866 (Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen) held by The Regents of the University of California expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P1/04